Aquestive Therapeutics, Inc.

AQST

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001398733

SEC filings (opens in a new tab)

In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Aquestive Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of AQST: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	114	2	121	+9
Shares	43.4M	237.2K	44.3M	+1.11M (+2.6%)
Value	$154.4M	$844.5K	$127.8M	−$25.8M (−16.8%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to AQST in Q1 2025
Institution	Shares	Value	% of portfolio
Perceptive Advisors LLC	3,727,208	$10.8M	0.38%
Sio Capital Management, LLC	391,629	$1.14M	0.34%
Nuveen, LLC	236,473	$685.8K	0.00%
Bridgeway Capital Management, LLC	167,700	$486.3K	0.01%
Dauntless Investment Group, LLC	91,540	$265.5K	0.98%
Penn Capital Management Co Inc	86,618	$251.2K	0.02%
XTX Topco Ltd	78,522	$227.7K	0.01%
Walleye Capital LLC	39,581	$114.8K	0.00%
Sugar Maple Asset Management, LLC	29,500	$85.5K	0.07%
Mariner, LLC	26,316	$76.3K	0.00%
Penbrook Management LLC	22,585	$65.5K	0.05%
Susquehanna Portfolio Strategies, LLC	20,531	$59.5K	0.03%
Virtu Financial LLC	20,075	$58.0K	0.00%
CIBC World Markets Corp	16,479	$47.8K	0.00%
Cambridge Investment Research Advisors, Inc.	11,303	$33.0K	0.00%
Victory Capital Management Inc	10,568	$30.6K	0.00%
Quinn Opportunity Partners LLC	10,100	$29.3K	0.00%
Summit Wealth & Retirement Planning, Inc.	10,000	$29.0K	0.01%
Picton Mahoney Asset Management	3,073	$8.00K	0.00%
Quantbot Technologies LP	851	$2.47K	0.00%
Caitong International Asset Management Co., Ltd	680	$1.97K	0.00%
Daiwa Securities Group Inc.	500	$1.00K	0.00%
Jones Financial Companies LLLP	200	$604	0.00%
Parkside Financial Bank & Trust	185	$536	0.00%
CoreCap Advisors, LLC	183	$531	0.00%
Quadrant Capital Group LLC	168	$488	0.00%
EverSource Wealth Advisors, LLC	144	$418	0.00%
True Wealth Design, LLC	28	$82	0.00%

Sold out (19)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of AQST in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
VR Adviser, LLC	2,629,786	$9.36M
Franklin Resources Inc	2,134,796	$7.60M
MPM Oncology Impact Management LP	1,611,833	$5.74M
Essex Investment Management Co LLC	623,310	$2.22M
Legato Capital Management LLC	186,424	$663.7K
Qube Research & Technologies Ltd	140,889	$501.6K
Renaissance Technologies LLC	95,400	$339.6K
Marshall Wace, LLP	55,695	$198.3K
Diametric Capital, LP	35,295	$125.7K
Jane Street Group, LLC	25,757	$91.7K
State of Wisconsin Investment Board	25,010	$89.0K
Simplex Trading, LLC	16,353	$58.0K
Dynamic Technology Lab Private Ltd	12,419	$44.0K
Clear Street Markets LLC	6,666	$23.7K
Caitlin John, LLC	5,900	$21.0K
State of Wyoming	5,229	$18.6K
Richard W. Paul & Associates, LLC	1,602	$5.70K
R Squared Ltd	1,010	$3.60K
IFP Advisors, Inc	10	$36

Not filed for Q1 2025 yet (2)

Institutions that held Aquestive Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AQST in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	236,473	$841.8K
Global Retirement Partners, LLC	750	$2.67K